Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma
Clinical trial NCT02141542 · COMPLETED
Trial details
- NCT number
- NCT02141542
- Sponsor
- F. Stephen Hodi, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2020-09-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.